Academic social network ResearchGate aids debunking of stem cell study

ResearchGate released their new feature "Open Review" with a drumroll. Here is the entire story on GigaOm:

Berlin-based ResearchGate, in which Bill Gates is a prominent investor, provided a platform for study results that led to highly embarrassing backpedaling from a Japanese research institute.

Update: Here is the Wallstreet Journal's piece on it.